<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">649</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2022-21-3-13-21</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Unstable abnormal hemoglobins found in Russia in the past 10 years</article-title><trans-title-group xml:lang="ru"><trans-title>Аномальные нестабильные гемоглобины, идентифицированные в России за последние 10 лет</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4222-2915</contrib-id><name-alternatives><name xml:lang="en"><surname>Lokhmatova</surname><given-names>M. E.</given-names></name><name xml:lang="ru"><surname>Лохматова</surname><given-names>М. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Marina E. Lokhmatova, Cand. Med. Sci., a hematologist, Headof the Outpatient Clinic</p><p>1 Samory Mashela St., 117997, Moscow, Russia</p></bio><bio xml:lang="ru"><p>Лохматова Марина Евгеньевна, канд. мед. наук, врач-гематолог, заведующая консультативным отделением</p><p>117997, Москва, ул. Саморы Машела, 1</p></bio><email>marina.lokhmatova@fccho-moscow.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1021-7348</contrib-id><name-alternatives><name xml:lang="en"><surname>Sokolova</surname><given-names>N. E.</given-names></name><name xml:lang="ru"><surname>Соколова</surname><given-names>Н. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0929-4792</contrib-id><name-alternatives><name xml:lang="en"><surname>Krasilnikova</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Красильникова</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6331-5339</contrib-id><name-alternatives><name xml:lang="en"><surname>Litvin</surname><given-names>E. A.</given-names></name><name xml:lang="ru"><surname>Литвин</surname><given-names>Е. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9865-527X</contrib-id><name-alternatives><name xml:lang="en"><surname>Karamjan</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Карамян</surname><given-names>Н. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1014-5196</contrib-id><name-alternatives><name xml:lang="en"><surname>Mann</surname><given-names>S. G.</given-names></name><name xml:lang="ru"><surname>Манн</surname><given-names>С. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4503-0735</contrib-id><name-alternatives><name xml:lang="en"><surname>Plyasunova</surname><given-names>S. A.</given-names></name><name xml:lang="ru"><surname>Плясунова</surname><given-names>С. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2756-7325</contrib-id><name-alternatives><name xml:lang="en"><surname>Smetanina</surname><given-names>N. S.</given-names></name><name xml:lang="ru"><surname>Сметанина</surname><given-names>Н. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-10-15" publication-format="electronic"><day>15</day><month>10</month><year>2022</year></pub-date><volume>21</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>13</fpage><lpage>21</lpage><history><date date-type="received" iso-8601-date="2022-10-10"><day>10</day><month>10</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-10-10"><day>10</day><month>10</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/649">https://hemoncim.com/jour/article/view/649</self-uri><abstract xml:lang="en"><p>From 2010 to 2020, we investigated 197 children with hemolytic anemia of unknown etiology at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. Fifty-four of them were found to have hemoglobinopathy caused by unstable abnormal hemoglobins: Hb Monroe/Kairouan, Hb Tacoma, Hb Köln/SanFrancisco, Hb Cheverly, Hb City of Hope, Hb Southampton/Casper, Hb M-Hyde Park/Akita/Milwaukee-2, Hb Buenos Aires/Bryn Mawr, Hb Louisville/Bucureşti, Hb Genova/Hyogo, Hb Roseau-Pointe a Pitre, Hb Bristol/Alesha, Hb Henri Mondor, Hb Knossos, Hb Leiden, Hb Little Venice, Hb Olmsted, Hb Sabine, Hb Showa-Yakushiji, Hb Terre Haute, Hb Tübingen, Hb Quin-Hai. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. The patients' parents signed the informed consent for molecular genetic testing and gave their consent to the use of their children's data, including photographs, for research purposes and in publications.</p></abstract><trans-abstract xml:lang="ru"><p>С 2010 по 2020 г. включительно в ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России обследованы 197 детей с гемолитической анемией неустановленной этиологии, у 54 из них выявлена гемоглобинопатия, обусловленная аномальным нестабильным гемоглобином: Hb Monroe/Kairouan, Hb Tacoma, Hb Köln/SanFrancisco, Hb Cheverly, Hb City of Hope, Hb Southampton/Casper, Hb M-Hyde Park/Akita/Milwaukee-2, Hb Buenos Aires/Bryn Mawr, Hb Louisville/Bucureşti, Hb Genova/Hyogo, Hb Roseau-Pointe a Pitre, Hb Bristol/Alesha, Hb Henri Mondor, Hb Knossos, Hb Leiden, Hb Little Venice, Hb Olmsted, Hb Sabine, Hb Showa-Yakushiji, Hb Terre Haute, Hb Tübingen, Hb Quin-Hai. Данное исследование одобрено независимым этическим комитетом и утверждено решением ученого совета НМИЦ ДГОИ им. Дмитрия Рогачева. Родители пациентов подписали информированное согласие на проведение молекулярно-генетического исследования и дали свое разрешение использовать персональные данные и фотографии детей в научных исследованиях и публикациях.</p></trans-abstract><kwd-group xml:lang="en"><kwd>thalassemia</kwd><kwd>hemoglobinopathies</kwd><kwd>unstable hemoglobin</kwd><kwd>hemolytic anemias</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>талассемия</kwd><kwd>гемоглобинопатии</kwd><kwd>нестабильный гемоглобин</kwd><kwd>гемолитические анемии</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. ВОЗ: Исполнительный комитет, 118-я сессия. Талассемия и другие гемоглобинопатии: доклад Секретариата. Женева; 2006.</mixed-citation><mixed-citation xml:lang="ru">ВОЗ: Исполнительный комитет, 118-я сессия. Талассемия и другие гемоглобинопатии: доклад Секретариата. Женева; 2006.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Гемоглобинопатии и талассемические синдромы. Под ред. Румянцева А.Г., Токарева Ю.Н., Сметаниной Н.С. М.: Практическая медицина; 2015. 448 с. С. 274–279.</mixed-citation><mixed-citation xml:lang="ru">Гемоглобинопатии и талассемические синдромы. Под ред. Румянцева А.Г., Токарева Ю.Н., Сметаниной Н.С. М.: Практическая медицина; 2015. 448 с. С. 274–279.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Landin B., Jeppsson J.O. Rare Beta Chain Hemoglobin Variants Found in Swedish Patients During HBA1c Analysis. Hemoglobin 1993; 17 (4): 303–18.</mixed-citation><mixed-citation xml:lang="ru">Landin B., Jeppsson J.O. Rare Beta Chain Hemoglobin Variants Found in Swedish Patients During HBA1c Analysis. Hemoglobin 1993; 17 (4): 303–18.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Sangkitporn S.K., Eksiri L., Sangnoi A., Duangruang S., Dumbua A., Rattanakittisophon K., et al. Identification of b‐globin gene mutations in Thailand using an automated fluorescence‐based DNA sequencer. Int J Lab Hematol 2009; 31 (5): 521–7.</mixed-citation><mixed-citation xml:lang="ru">Sangkitporn S.K., Eksiri L., Sangnoi A., Duangruang S., Dumbua A., Rattanakittisophon K., et al. Identification of b‐globin gene mutations in Thailand using an automated fluorescence‐based DNA sequencer. Int J Lab Hematol 2009; 31 (5): 521–7.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Harano K., Harano T., Ueda S., Mori H., Shibata S., Takeda I., et al. Hb Tacoma [Beta30(B12)Arg→Ser], a Slightly Unstable Hemoglobin Variant Found in Japan. Hemoglobin 1985; 9 (6): 635–9.</mixed-citation><mixed-citation xml:lang="ru">Harano K., Harano T., Ueda S., Mori H., Shibata S., Takeda I., et al. Hb Tacoma [Beta30(B12)Arg→Ser], a Slightly Unstable Hemoglobin Variant Found in Japan. Hemoglobin 1985; 9 (6): 635–9.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Landin B., Alvelius G., Rai D.K., Elinder G. Compound Heterozygosity for Hb Tacoma [b30(B12)Arg→Ser] and b+-Thalassemia. Hemoglobin 2000; 24 (3): 253–7.</mixed-citation><mixed-citation xml:lang="ru">Landin B., Alvelius G., Rai D.K., Elinder G. Compound Heterozygosity for Hb Tacoma [b30(B12)Arg→Ser] and b+-Thalassemia. Hemoglobin 2000; 24 (3): 253–7.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Warang P., Nair S., Nadkarni A., Kedar P., Bhave A., Ghosh K., et al. Hb Köln [b98(FG5) [GTG→ATG, Val→Met]: The First Report From India. Hematology 2014; 19 (4): 199–201.</mixed-citation><mixed-citation xml:lang="ru">Warang P., Nair S., Nadkarni A., Kedar P., Bhave A., Ghosh K., et al. Hb Köln [b98(FG5) [GTG→ATG, Val→Met]: The First Report From India. Hematology 2014; 19 (4): 199–201.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Mittal N., Garg A., Kashyap R., Agarwal S. A Case of Compound Heterozygous Hemoglobin Köln/hemoglobin E in an Indian Family. Pediatr Hematol Oncol 2019; 36 (6): 394–8.</mixed-citation><mixed-citation xml:lang="ru">Mittal N., Garg A., Kashyap R., Agarwal S. A Case of Compound Heterozygous Hemoglobin Köln/hemoglobin E in an Indian Family. Pediatr Hematol Oncol 2019; 36 (6): 394–8.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Li Y.-Q., Ye L.-H., Mo Y. Detection of the Unstable Hb Köln (HBB: c.295G&gt;A) by a Capillary Electrophoresis Method. Hemoglobin 2016; 40 (6): 417–9.</mixed-citation><mixed-citation xml:lang="ru">Li Y.-Q., Ye L.-H., Mo Y. Detection of the Unstable Hb Köln (HBB: c.295G&gt;A) by a Capillary Electrophoresis Method. Hemoglobin 2016; 40 (6): 417–9.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Carrell R.W., Lehmann H., Hutchison H.E. Haemoglobin Köln (beta-98 valine-methionine): an unstable protein causing inclusion-body anaemia. Nature 1966; 210 (5039): 915–6.</mixed-citation><mixed-citation xml:lang="ru">Carrell R.W., Lehmann H., Hutchison H.E. Haemoglobin Köln (beta-98 valine-methionine): an unstable protein causing inclusion-body anaemia. Nature 1966; 210 (5039): 915–6.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Ricco G., Ravazzolo R., Rege-Cambrin G., Capaldi A., Trento M., Lecchi M., et al. Köln haemoglobinopathy in Italy. Panminerva Med 1981; 23 (4): 227–33.</mixed-citation><mixed-citation xml:lang="ru">Ricco G., Ravazzolo R., Rege-Cambrin G., Capaldi A., Trento M., Lecchi M., et al. Köln haemoglobinopathy in Italy. Panminerva Med 1981; 23 (4): 227–33.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Сметанина Н.С., Жесткова Н.М., Молчанова Т.П., Токарев Ю.Н. Гемоглобинопатия Köln: трое больных в одной русской семье. Терапевтический архив 1993; 65(7): 45–8.</mixed-citation><mixed-citation xml:lang="ru">Сметанина Н.С., Жесткова Н.М., Молчанова Т.П., Токарев Ю.Н. Гемоглобинопатия Köln: трое больных в одной русской семье. Терапевтический архив 1993; 65(7): 45–8.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. El-Kalla S., Mathews A.R. A Significant Beta-Thalassemia Heterogeneity in the United Arab Emirates. Hemoglobin 1997; 21 (3): 237–47.</mixed-citation><mixed-citation xml:lang="ru">El-Kalla S., Mathews A.R. A Significant Beta-Thalassemia Heterogeneity in the United Arab Emirates. Hemoglobin 1997; 21 (3): 237–47.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Teh L.K., George E., Lai M.I., Ai J., Tan M.A., Wong L., et al. Molecular Basis of Transfusion Dependent Beta-Thalassemia Major Patients in Sabah. J Hum Genet 2014; 59 (3): 119–23.</mixed-citation><mixed-citation xml:lang="ru">Teh L.K., George E., Lai M.I., Ai J., Tan M.A., Wong L., et al. Molecular Basis of Transfusion Dependent Beta-Thalassemia Major Patients in Sabah. J Hum Genet 2014; 59 (3): 119–23.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Moosa M.M., Ayub M.I., Bashar A.E., Sarwardi G., Khan W., Khan H., et al. Combination of Two Rare Mutations Causes b-Thalassaemia in a Bangladeshi Patient. Genet Mol Biol 2011; 34 (3): 406–9.</mixed-citation><mixed-citation xml:lang="ru">Moosa M.M., Ayub M.I., Bashar A.E., Sarwardi G., Khan W., Khan H., et al. Combination of Two Rare Mutations Causes b-Thalassaemia in a Bangladeshi Patient. Genet Mol Biol 2011; 34 (3): 406–9.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Sweeting I., Serjeant B.E., Serjeant G.R., Kulozik A.E., Vetter B. Short Communication: HB S-HB Monroe; a Sickle Cell-b-Thalassemia Syndrome. Hemoglobin 1998; 22 (2): 153–6.</mixed-citation><mixed-citation xml:lang="ru">Sweeting I., Serjeant B.E., Serjeant G.R., Kulozik A.E., Vetter B. Short Communication: HB S-HB Monroe; a Sickle Cell-b-Thalassemia Syndrome. Hemoglobin 1998; 22 (2): 153–6.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Gonzalez-Redondo J.M., Stoming T.A., Lanclos K.D., Gu Y.C., Kutlar A., Kutlar F., et al. Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States. Blood 1988; 72: 1007–14.</mixed-citation><mixed-citation xml:lang="ru">Gonzalez-Redondo J.M., Stoming T.A., Lanclos K.D., Gu Y.C., Kutlar A., Kutlar F., et al. Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States. Blood 1988; 72: 1007–14.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Varawalla N.Y., Old J.M., Sarkar R., Venkatesan R., Weatherall D.J. The spectrum of beta-thalassaemia mutations on the Indian subcontinent: The basis for prenatal diagnosis. Br J Haematol 1991; 78: 242–7.</mixed-citation><mixed-citation xml:lang="ru">Varawalla N.Y., Old J.M., Sarkar R., Venkatesan R., Weatherall D.J. The spectrum of beta-thalassaemia mutations on the Indian subcontinent: The basis for prenatal diagnosis. Br J Haematol 1991; 78: 242–7.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Fattoum S., Guemira F., Oner C., Oner R., Li H.W., Kutlar F., et al. Betathalassemia, Hb S-beta-thalassemia, and sickle cell anemia among Tunisians. Hemoglobin 1991; 15: 11–21.</mixed-citation><mixed-citation xml:lang="ru">Fattoum S., Guemira F., Oner C., Oner R., Li H.W., Kutlar F., et al. Betathalassemia, Hb S-beta-thalassemia, and sickle cell anemia among Tunisians. Hemoglobin 1991; 15: 11–21.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Fedorov A.N., Nasyrova F., Smirnova E.A., Bocharova T.N., Limborska S.A. IVS-I-1 (G&gt;C) in combination with -42 (C&gt;G) in the promoter region of the beta-globin gene in patients from Tajikistan. Hemoglobin 1993; 17: 275–8.</mixed-citation><mixed-citation xml:lang="ru">Fedorov A.N., Nasyrova F., Smirnova E.A., Bocharova T.N., Limborska S.A. IVS-I-1 (G&gt;C) in combination with -42 (C&gt;G) in the promoter region of the beta-globin gene in patients from Tajikistan. Hemoglobin 1993; 17: 275–8.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. Sarookhani M.R., Ahmadi M.H. Rare and unexpected beta-thalassemic mutations in Qazvin Province of Iran. African J Biotech 2010; 9: 95–101.</mixed-citation><mixed-citation xml:lang="ru">Sarookhani M.R., Ahmadi M.H. Rare and unexpected beta-thalassemic mutations in Qazvin Province of Iran. African J Biotech 2010; 9: 95–101.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22. Merault G., Keclard L., Saint-Martin C., Jasmin K., Campier A., Delanoe-Garin J., et al. Hemoglobin Roseau-Pointe a Pitre a2b290 (F6) Glu→Gly: a new hemoglobin variant with slight instability and low oxygen affinity. FEBS Lett 1985; 184 (1): 10–3.</mixed-citation><mixed-citation xml:lang="ru">Merault G., Keclard L., Saint-Martin C., Jasmin K., Campier A., Delanoe-Garin J., et al. Hemoglobin Roseau-Pointe a Pitre a2b290 (F6) Glu→Gly: a new hemoglobin variant with slight instability and low oxygen affinity. FEBS Lett 1985; 184 (1): 10–3.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23. Liu J., Huang Y., Lei Y., Lai Y. Hb Southampton [b106(G8)Leu→Pro; HBB: c.320T&gt;C] and Codons 41/42 (-TTCT; HBB: c.124_127delTTCT) in a Chinese Girl. Hemoglobin 2017; 41 (2): 134–6.</mixed-citation><mixed-citation xml:lang="ru">Liu J., Huang Y., Lei Y., Lai Y. Hb Southampton [b106(G8)Leu→Pro; HBB: c.320T&gt;C] and Codons 41/42 (-TTCT; HBB: c.124_127delTTCT) in a Chinese Girl. Hemoglobin 2017; 41 (2): 134–6.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24. Gómez V.A., Eberle S.E., Pepe C., Sciuccati G., Rosolen N.G., Cervio C., et al. Severe Hemolytic Anemia Due to Hemoglobin Southampton: Case Report. Arch Argent Pediatr 2012; 110 (5): e91–4.</mixed-citation><mixed-citation xml:lang="ru">Gómez V.A., Eberle S.E., Pepe C., Sciuccati G., Rosolen N.G., Cervio C., et al. Severe Hemolytic Anemia Due to Hemoglobin Southampton: Case Report. Arch Argent Pediatr 2012; 110 (5): e91–4.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">25. Heintz N.H., Howard P.L. Hemoglobin Southampton (Casper): Characterization of the Base Mutation. Am J Hematol 1989; 30 (1): 1–3.</mixed-citation><mixed-citation xml:lang="ru">Heintz N.H., Howard P.L. Hemoglobin Southampton (Casper): Characterization of the Base Mutation. Am J Hematol 1989; 30 (1): 1–3.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">26. Da Luz Pereira J.A., López P., Costa F.F., Sans M., de Fatima Sonati M. Hb Southampton [B106(G8) Leu→PRO, CTG→CCG] in a Uruguayan Woman. Rev Bras Hematol Hemoter 2013; 35 (2): 146–7.</mixed-citation><mixed-citation xml:lang="ru">Da Luz Pereira J.A., López P., Costa F.F., Sans M., de Fatima Sonati M. Hb Southampton [B106(G8) Leu→PRO, CTG→CCG] in a Uruguayan Woman. Rev Bras Hematol Hemoter 2013; 35 (2): 146–7.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">27. Wada Y., Hayashi A., Fujita T., Matsuo T., Katakuse I., Matsuda H. Structural Analysis of Human Hemoglobin Variants With Field Desorption Mass Spectrometry. Biochim Biophys Acta 1981; 667 (2): 233–41.</mixed-citation><mixed-citation xml:lang="ru">Wada Y., Hayashi A., Fujita T., Matsuo T., Katakuse I., Matsuda H. Structural Analysis of Human Hemoglobin Variants With Field Desorption Mass Spectrometry. Biochim Biophys Acta 1981; 667 (2): 233–41.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">28. Wong S.C., Ali M.A., Pai M., Barr R.D. A new case of the unstable haemoglobin Genova (Alpha 2 Beta 2 28 (Beta 10) leu leads to pro) in Canada: as a result of sporadic mutation and causing Heinz body haemolytic anaemia. Acta Haematol 1980; 63 (4): 222–5.</mixed-citation><mixed-citation xml:lang="ru">Wong S.C., Ali M.A., Pai M., Barr R.D. A new case of the unstable haemoglobin Genova (Alpha 2 Beta 2 28 (Beta 10) leu leads to pro) in Canada: as a result of sporadic mutation and causing Heinz body haemolytic anaemia. Acta Haematol 1980; 63 (4): 222–5.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">29. Solal M.C., Labie D. A New Case of Hemoglobin Genova a2b2 28(B10) Leu leads to Pro. Further Studies on the Mechanism of Instability and Defective Synthesis. Biochim Biophys Acta 1973; 295 (1): 67–76.</mixed-citation><mixed-citation xml:lang="ru">Solal M.C., Labie D. A New Case of Hemoglobin Genova a2b2 28(B10) Leu leads to Pro. Further Studies on the Mechanism of Instability and Defective Synthesis. Biochim Biophys Acta 1973; 295 (1): 67–76.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">30. Hopmeier P., Binder C., Gadner H., Fischer M. A case of the unstable Hb Genova (beta 28 Leu&gt;Pro) in an Arab child associated with severe haemolytic anaemia and growth retardation. Acta Haematol 1990; 83 (1): 39–41.</mixed-citation><mixed-citation xml:lang="ru">Hopmeier P., Binder C., Gadner H., Fischer M. A case of the unstable Hb Genova (beta 28 Leu&gt;Pro) in an Arab child associated with severe haemolytic anaemia and growth retardation. Acta Haematol 1990; 83 (1): 39–41.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">31. Martínez G., Carnot J., Hernández P. Hb Genova in a Cuban family. Clinical differences between carriers. Hemoglobin 1983; 7 (6): 591–4.</mixed-citation><mixed-citation xml:lang="ru">Martínez G., Carnot J., Hernández P. Hb Genova in a Cuban family. Clinical differences between carriers. Hemoglobin 1983; 7 (6): 591–4.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">32. Kendall A., Young S., Oune N., Wiltshire B., Lehmann H. The unstable Hb Genova (beta 28Leu replaced by Pro) in an East African Family. Family study and the effect of splenectomy. Acta Haematol 1979; 61 (5): 278–82.</mixed-citation><mixed-citation xml:lang="ru">Kendall A., Young S., Oune N., Wiltshire B., Lehmann H. The unstable Hb Genova (beta 28Leu replaced by Pro) in an East African Family. Family study and the effect of splenectomy. Acta Haematol 1979; 61 (5): 278–82.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">33. Nabhani I.A., Aneke J.C., Verhovsek M., Eng B., Kuo K.H., Rudinskas L.C., et al. Novel High Oxygen Affinity Hemoglobin Variant in a Patient With Polycythemia: Hb Kennisis [b85(F1)Phe→Leu (TT T&gt;TT G); HBB: c.258T&gt;G]. Hemoglobin 2020; 44 (1): 10–2.</mixed-citation><mixed-citation xml:lang="ru">Nabhani I.A., Aneke J.C., Verhovsek M., Eng B., Kuo K.H., Rudinskas L.C., et al. Novel High Oxygen Affinity Hemoglobin Variant in a Patient With Polycythemia: Hb Kennisis [b85(F1)Phe→Leu (TT T&gt;TT G); HBB: c.258T&gt;G]. Hemoglobin 2020; 44 (1): 10–2.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">34. Larson P.J., Friedman D.F., Reilly M.P., Kattamis A.C., Asakura T., Fortina P., et al. The presurgical management with erythrocytapheresis of a patient with a high-oxygen-affinity, unstable Hb variant (Hb Bryn Mawr). Transfusion 1997; 37 (7): 703–7.</mixed-citation><mixed-citation xml:lang="ru">Larson P.J., Friedman D.F., Reilly M.P., Kattamis A.C., Asakura T., Fortina P., et al. The presurgical management with erythrocytapheresis of a patient with a high-oxygen-affinity, unstable Hb variant (Hb Bryn Mawr). Transfusion 1997; 37 (7): 703–7.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">35. Hiratake S., Komada Y., Ito M., Azuma E., Sakurai M., Harano T.. The First Case in Japan of Unstable Hemoglobin, Hb Buenos Aires [Beta 85 (F1) Phe&gt;Ser], With Parvovirus B19 Infection (First Case in Japan). Rinsho Ketsueki 1995; 36 (12): 1342–6.</mixed-citation><mixed-citation xml:lang="ru">Hiratake S., Komada Y., Ito M., Azuma E., Sakurai M., Harano T.. The First Case in Japan of Unstable Hemoglobin, Hb Buenos Aires [Beta 85 (F1) Phe&gt;Ser], With Parvovirus B19 Infection (First Case in Japan). Rinsho Ketsueki 1995; 36 (12): 1342–6.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">36. De Weinstein B.I., White J.M., Wiltshire B.G., Lehmann H. a new unstable haemoglobin: Hb Buenos Aires, beta 85 (F1) Phe leads to Ser. Acta Haematol 1973; 50 (6): 357–63.</mixed-citation><mixed-citation xml:lang="ru">De Weinstein B.I., White J.M., Wiltshire B.G., Lehmann H. a new unstable haemoglobin: Hb Buenos Aires, beta 85 (F1) Phe leads to Ser. Acta Haematol 1973; 50 (6): 357–63.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">37. Kamseng P., Trakulsrichai S., Trachoo O., Yimniam W., Panthan B., Jittorntam P., et al. Low Oxygen Saturation and Severe Anemia in Compound Heterozygous Hb Louisville [b42(CD1) Phe→Leu] and Hb La Desirade [b129(H7)Ala→Val]. Hematology 2017; 22 (2): 114–8.</mixed-citation><mixed-citation xml:lang="ru">Kamseng P., Trakulsrichai S., Trachoo O., Yimniam W., Panthan B., Jittorntam P., et al. Low Oxygen Saturation and Severe Anemia in Compound Heterozygous Hb Louisville [b42(CD1) Phe→Leu] and Hb La Desirade [b129(H7)Ala→Val]. Hematology 2017; 22 (2): 114–8.</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">38. Keeling M.M., Ogden L.L., Wrightstone R.N., Wilson J.B., Reynolds C.A., Kitchens J.L., et al. Hemoglobin Louisville (beta-42 (CD1) Phe-Leu): An Unstable Variant Causing Mild Hemolytic Anemia. J Clin Invest 1971; 50 (11): 2395–402.</mixed-citation><mixed-citation xml:lang="ru">Keeling M.M., Ogden L.L., Wrightstone R.N., Wilson J.B., Reynolds C.A., Kitchens J.L., et al. Hemoglobin Louisville (beta-42 (CD1) Phe-Leu): An Unstable Variant Causing Mild Hemolytic Anemia. J Clin Invest 1971; 50 (11): 2395–402.</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">39. Wu Y., Ramani G.V., Gai Q., Lemon L.C., Baer M.R. Rare hemoglobinopathy presenting as progressive dyspnea. Am J Hematol 2010; 85 (5): 355–7.</mixed-citation><mixed-citation xml:lang="ru">Wu Y., Ramani G.V., Gai Q., Lemon L.C., Baer M.R. Rare hemoglobinopathy presenting as progressive dyspnea. Am J Hematol 2010; 85 (5): 355–7.</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">40. Lorenzo-Medina M., de la Iglesia S., Ruiz-García L., Quintana-Hidalgo L., Martín-Alfaro R., Herrada J. Pitfalls of glycated hemoglobin in the glycemic assessment of diabetes patients with hemoglobin Louisville: role of serum fructosamine. J Diabetes Sci Technol 2013; 7 (3): 804–5.</mixed-citation><mixed-citation xml:lang="ru">Lorenzo-Medina M., de la Iglesia S., Ruiz-García L., Quintana-Hidalgo L., Martín-Alfaro R., Herrada J. Pitfalls of glycated hemoglobin in the glycemic assessment of diabetes patients with hemoglobin Louisville: role of serum fructosamine. J Diabetes Sci Technol 2013; 7 (3): 804–5.</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">41. Von Planta M., Humbert J., Wacker P., Rimensberger P.C., Darbellay R., Roosnek E., et al. Hypothesis for generation of the unstable Hb Bucuresti (beta 42 Phe--&gt;Leu) mutation. Hematol J 2001; 2 (1): 61–6.</mixed-citation><mixed-citation xml:lang="ru">Von Planta M., Humbert J., Wacker P., Rimensberger P.C., Darbellay R., Roosnek E., et al. Hypothesis for generation of the unstable Hb Bucuresti (beta 42 Phe--&gt;Leu) mutation. Hematol J 2001; 2 (1): 61–6.</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">42. Smiley R.K., Gravely M.E., Wilson J.B., Huisman T.J.H. Hemoglobin Louisville (beta 42 (CD1) phenylalanine replaced by leucine) occurring as a fresh mutation in a Canadian woman. Hemoglobin 1978; 2 (1): 89–90.</mixed-citation><mixed-citation xml:lang="ru">Smiley R.K., Gravely M.E., Wilson J.B., Huisman T.J.H. Hemoglobin Louisville (beta 42 (CD1) phenylalanine replaced by leucine) occurring as a fresh mutation in a Canadian woman. Hemoglobin 1978; 2 (1): 89–90.</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">43. Philippe M., Larondelle Y., Vaerman J.L., Martiat P., Galacteros F., Wajcman H., Lambert M. Hb Tübingen [alpha 2 beta (2)106(G8)Leu--&gt;Gln] in a Belgian Family. Hemoglobin 1993; 17 (4): 373–8. DOI: 10.3109/03630269308997490</mixed-citation><mixed-citation xml:lang="ru">Philippe M., Larondelle Y., Vaerman J.L., Martiat P., Galacteros F., Wajcman H., Lambert M. Hb Tübingen [alpha 2 beta (2)106(G8)Leu--&gt;Gln] in a Belgian Family. Hemoglobin 1993; 17 (4): 373–8. DOI: 10.3109/03630269308997490</mixed-citation></citation-alternatives></ref></ref-list></back></article>
